How personalized healthcare is revolutionizing how we fight cancer
IBM
To keep up with the differences in our bodies and the wealth of information out there, doctors are increasingly getting assistance - particularly in treating cancer - from a sophisticated technological source: IBM Watson Health.
In creating cognitive healthcare solutions, IBM teamed up with oncologists to sift through available data from around the world, gaining comprehensive and up-to-date insights on cancer-causing mutations.
Lightning-fast medical insights
One of the most difficult and complex diseases to treat is cancer. Most of the 1.6 million Americans who are diagnosed with cancer each year receive surgery, chemotherapy, or radiation treatment. Yet when standard treatments fail and as genetic sequencing becomes increasingly accessible and affordable, some patients are beginning to benefit from treatments that target their specific cancer-causing genetic mutations.
Watson for Genomics helps clinicians to analyze each mutation, then identify tailored treatment options for patients. Without Watson, this kind of personalized treatment can take weeks.
With Watson, oncologists can produce a report and data visualization of the patient's case, along with evidence-based insights on relevant potential drugs that are recommended for an individual patient's DNA profile. Watson Health provides this in minutes.
Oncologist Norman Sharpless, Director, UNC Lineberger Comprehensive Cancer Center told IBM that what first impressed him about Watson was that it could "read and ingest disparate sources of data on a single patient." In a demo from MD Anderson Cancer Center, he watched as Watson read the chest X-ray, the electrocardiogram, and the physician notes. It looked at the pathology results and incorporated all of the data.
Sharpless says some of the data were "images, a PDF, and some of it was spoken word." Watson easily made sense of it all and tied it together into something an oncologist could review quickly.
Partnering with Watson Health
To develop Watson for Genomics, IBM Watson Health collaborates with more than a dozen leading cancer institutes, including the New York Genome Center, Columbia University Medical Center, University of North Carolina, Washington University, and more.
Partners use Watson to look for variations in the patient's genome. Then it examines data sources such as treatment guidelines, research, clinical studies, journal articles, and patient information, and provides a list of medical literature that's relevant to the case, along with drugs that have been identified in the literature.
The patient's doctor reviews this information alongside underlying evidence to make more informed treatment decisions. Watson for Genomics constantly gets smarter as the system learns from patient data.
IBM Watson Health is bringing the promise of personalized healthcare closer to reality for everyone. And that's a huge step forward. Or as Norman Sharpless told IBM, "It used to be that cancer was so mysterious that it was hard to figure out how we were going to beat it, but I think now most oncologists feel we have a path to victory."
Find out more about IBM Watson Health.
This post is sponsored by IBM.
Find out more about Sponsored Content.
- Stock markets stage strong rebound after 4 days of slump; Sensex rallies 599 pts
- Sustainable Transportation Alternatives
- 10 Foods you should avoid eating when in stress
- 8 Lesser-known places to visit near Nainital
- World Liver Day 2024: 10 Foods that are necessary for a healthy liver